NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews has proposed a private placement of its common shares that would bring in proceeds of C$2 million (US$1.9 million).

The firm is planning to place 4,444,444 common shares at a price of $.45 per share. It said that an unidentified labor-sponsored investment fund will subscribe for half of those shares at a total price of C$1 million, with the remainder of the shares being purchased by "arm's length parties."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.